These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36382241)

  • 1. Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics.
    da Cruz Freire JE; Júnior JEM; Pinheiro DP; da Cruz Paiva Lima GE; do Amaral CL; Veras VR; Madeira MP; Freire EBL; Ozório RG; Fernandes VO; Montenegro APDR; Montenegro RC; Colares JKB; Júnior RMM
    3 Biotech; 2022 Dec; 12(12):344. PubMed ID: 36382241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral phytocompounds "ellagic acid" and "(+)-sesamin" of
    Umar AK; Zothantluanga JH; Aswin K; Maulana S; Sulaiman Zubair M; Lalhlenmawia H; Rudrapal M; Chetia D
    Struct Chem; 2022; 33(5):1445-1465. PubMed ID: 35571865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CL
    Rao P; Shukla A; Parmar P; Rawal RM; Patel BV; Saraf M; Goswami D
    J Biomol Struct Dyn; 2022 Jan; 40(1):348-360. PubMed ID: 32875950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of chalcones as 3-chymotrypsin-like protease (3CL
    Lam TP; Nguyen DN; Mai TT; Tran TD; Le MT; Huynh PNH; Nguyen DT; Tran VH; Trinh DT; Truong P; Vo CT; Thai KM
    Struct Chem; 2022; 33(5):1707-1725. PubMed ID: 35811783
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
    J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3CL
    Štekláč M; Zajaček D; Bučinský L
    J Mol Struct; 2021 Dec; 1245():130968. PubMed ID: 34219808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation.
    Bepari AK; Reza HM
    PeerJ; 2021; 9():e11261. PubMed ID: 33954055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioactive compounds of Jingfang Granules against SARS-CoV-2 virus proteases 3CL
    Shang ZP; Yi Y; Yu R; Fan JJ; Huang YX; Qiao X; Ye M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):907-919. PubMed ID: 36241233
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Cheohen CFAR; Esteves MEA; da Fonseca TS; Leal CM; Assis FLF; Campos MF; Rebelo RS; Allonso D; Leitão GG; da Silva ML; Leitão SG
    Comput Struct Biotechnol J; 2023; 21():1461-1472. PubMed ID: 36817956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL
    Verma D; Mitra D; Paul M; Chaudhary P; Kamboj A; Thatoi H; Janmeda P; Jain D; Panneerselvam P; Shrivastav R; Pant K; Das Mohapatra PK
    Curr Res Pharmacol Drug Discov; 2021; 2():100038. PubMed ID: 34870149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the mechanism of active components of Liupao tea on 3CL
    Ni WJ; Chen XX; Wei SY; Lan LL; Qiu RJ; Ling YP; Zhou DS; Wu ZM; Cao ZH; Yu CP; Zeng Y
    J Food Biochem; 2021 May; 45(5):e13707. PubMed ID: 33760271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL
    Bhowmik D; Sharma RD; Prakash A; Kumar D
    J Mol Struct; 2021 Jun; 1233():130094. PubMed ID: 33612858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Some Antiviral Natural Products to Fight Against Novel Coronavirus (SARS-CoV-2) Using an
    Shah A; Patel V; Parmar B
    Comb Chem High Throughput Screen; 2021; 24(8):1271-1280. PubMed ID: 32881661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
    Arouche TDS; Martins AY; Ramalho TC; Júnior RNC; Costa FLP; Filho TSA; Neto AMJC
    J Nanosci Nanotechnol; 2021 Apr; 21(4):2075-2089. PubMed ID: 33500022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Delgado CP; Rocha JBT; Orian L; Bortoli M; Nogara PA
    Struct Chem; 2022; 33(6):2205-2220. PubMed ID: 36106095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational identification of small molecules derived from 9,10-dihydrophenanthrene as potential inhibitors of 3CL
    Daoui O; Elkhattabi S; Chtita S
    Struct Chem; 2022; 33(5):1667-1690. PubMed ID: 35818588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL
    Gyebi GA; Ogunro OB; Adegunloye AP; Ogunyemi OM; Afolabi SO
    J Biomol Struct Dyn; 2021 Jun; 39(9):3396-3408. PubMed ID: 32367767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silybin B and Cianidanol Inhibit M
    Srivastava R; Tripathi S; Unni S; Hussain A; Haque S; Dasgupta N; Singh V; Mishra BN
    Curr Pharm Des; 2021; 27(32):3476-3489. PubMed ID: 33302853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.